Literature DB >> 19286661

Plasmin-mediated proteolysis is required for hepatocyte growth factor activation during liver repair.

Kumar Shanmukhappa1, Ursula Matte, Jay L Degen, Jorge A Bezerra.   

Abstract

The physiological relevance of the activation of hepatocyte growth factor (Hgf) by the plasminogen (Plg) system of proteases and its contribution to tissue repair are largely undefined. Here, we investigated whether the defective liver repair in mice lacking Plg is due to impaired activation of Hgf. Loss of Plg in vivo suppressed Hgf activation and signaling through its Met tyrosine kinase receptor. Without Plg, hepatocytes were unresponsive to Hgf-induced proliferation and migration, with a more pronounced impairment in hepatocyte movement within the hepatic environment. Most notably, circumventing the defect in proteolytic activation of Hgf by the downstream expression of an activated Met receptor corrected the functional deficits and improved liver repair in Plg-deficient mice. These findings support a fibrinolysis-unrelated role for Plg in modulating cell proliferation and migration by activation of Hgf.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19286661      PMCID: PMC2676022          DOI: 10.1074/jbc.M807313200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  31 in total

1.  Hepatocyte growth factor suppresses the onset of liver cirrhosis and abrogates lethal hepatic dysfunction in rats.

Authors:  Y Matsuda; K Matsumoto; T Ichida; T Nakamura
Journal:  J Biochem       Date:  1995-09       Impact factor: 3.387

2.  Pro-urokinase-type plasminogen activator is a substrate for hepsin.

Authors:  Paul Moran; Wei Li; Bin Fan; Rajesh Vij; Charles Eigenbrot; Daniel Kirchhofer
Journal:  J Biol Chem       Date:  2006-08-14       Impact factor: 5.157

3.  Temporal and tissue-specific expression of the MET ORF driven by the complete transcriptional unit of human A1AT gene in transgenic mice.

Authors:  L Amicone; M A Galimi; F M Spagnoli; C Tommasini; V De Luca; M Tripodi
Journal:  Gene       Date:  1995-09-11       Impact factor: 3.688

4.  Processing of hepatocyte growth factor to the heterodimeric form is required for biological activity.

Authors:  E Gak; W G Taylor; A M Chan; J S Rubin
Journal:  FEBS Lett       Date:  1992-10-12       Impact factor: 4.124

5.  Activation of hepatocyte growth factor by the plasminogen activators uPA and tPA.

Authors:  W M Mars; R Zarnegar; G K Michalopoulos
Journal:  Am J Pathol       Date:  1993-09       Impact factor: 4.307

6.  Hepatocyte growth factor increases urokinase-type plasminogen activator (u-PA) and u-PA receptor expression in Madin-Darby canine kidney epithelial cells.

Authors:  M S Pepper; K Matsumoto; T Nakamura; L Orci; R Montesano
Journal:  J Biol Chem       Date:  1992-10-05       Impact factor: 5.157

7.  Direct evidence that hepatocyte growth factor is a hepatotrophic factor for liver regeneration and has a potent antihepatitis effect in vivo.

Authors:  Y Ishiki; H Ohnishi; Y Muto; K Matsumoto; T Nakamura
Journal:  Hepatology       Date:  1992-11       Impact factor: 17.425

8.  Biological activation of pro-HGF (hepatocyte growth factor) by urokinase is controlled by a stoichiometric reaction.

Authors:  L Naldini; E Vigna; A Bardelli; A Follenzi; F Galimi; P M Comoglio
Journal:  J Biol Chem       Date:  1995-01-13       Impact factor: 5.157

9.  The plasminogen activation system reduces fibrosis in the lung by a hepatocyte growth factor-dependent mechanism.

Authors:  Noboru Hattori; Shinya Mizuno; Yuka Yoshida; Kazuo Chin; Michiaki Mishima; Thomas H Sisson; Richard H Simon; Toshikazu Nakamura; Masayuki Miyake
Journal:  Am J Pathol       Date:  2004-03       Impact factor: 4.307

10.  Extracellular proteolytic cleavage by urokinase is required for activation of hepatocyte growth factor/scatter factor.

Authors:  L Naldini; L Tamagnone; E Vigna; M Sachs; G Hartmann; W Birchmeier; Y Daikuhara; H Tsubouchi; F Blasi; P M Comoglio
Journal:  EMBO J       Date:  1992-12       Impact factor: 11.598

View more
  12 in total

1.  The antifibrotic effects of plasminogen activation occur via prostaglandin E2 synthesis in humans and mice.

Authors:  Kristy A Bauman; Scott H Wettlaufer; Katsuhide Okunishi; Kevin M Vannella; Joshua S Stoolman; Steven K Huang; Anthony J Courey; Eric S White; Cory M Hogaboam; Richard H Simon; Galen B Toews; Thomas H Sisson; Bethany B Moore; Marc Peters-Golden
Journal:  J Clin Invest       Date:  2010-05-24       Impact factor: 14.808

2.  Steady states and dynamics of urokinase-mediated plasmin activation in silico and in vitro.

Authors:  Lakshmi Venkatraman; Huipeng Li; C Forbes Dewey; Jacob K White; Sourav S Bhowmick; Hanry Yu; Lisa Tucker-Kellogg
Journal:  Biophys J       Date:  2011-10-19       Impact factor: 4.033

3.  A novel animal model for in vivo study of liver cancer metastasis.

Authors:  Shinsuke Fujiwara; Hikaru Fujioka; Chise Tateno; Ken Taniguchi; Masahiro Ito; Hiroshi Ohishi; Rie Utoh; Hiromi Ishibashi; Takashi Kanematsu; Katsutoshi Yoshizato
Journal:  World J Gastroenterol       Date:  2012-08-07       Impact factor: 5.742

4.  Paracrine signals regulate human liver organoid maturation from induced pluripotent stem cells.

Authors:  Akihiro Asai; Eitaro Aihara; Carey Watson; Reena Mourya; Tatsuki Mizuochi; Pranavkumar Shivakumar; Kieran Phelan; Christopher Mayhew; Michael Helmrath; Takanori Takebe; James Wells; Jorge A Bezerra
Journal:  Development       Date:  2017-03-15       Impact factor: 6.868

5.  Plasminogen Deficiency Delays the Onset and Protects from Demyelination and Paralysis in Autoimmune Neuroinflammatory Disease.

Authors:  Maureen A Shaw; Zhen Gao; Kathryn E McElhinney; Sherry Thornton; Matthew J Flick; Adam Lane; Jay L Degen; Jae Kyu Ryu; Katerina Akassoglou; Eric S Mullins
Journal:  J Neurosci       Date:  2017-03-08       Impact factor: 6.167

6.  Plasmin is essential in preventing periodontitis in mice.

Authors:  Rima Sulniute; Tomas Lindh; Malgorzata Wilczynska; Jinan Li; Tor Ny
Journal:  Am J Pathol       Date:  2011-06-02       Impact factor: 4.307

7.  Targeting tumor cell invasion and dissemination in vivo by an aptamer that inhibits urokinase-type plasminogen activator through a novel multifunctional mechanism.

Authors:  Kenneth A Botkjaer; Elena I Deryugina; Daniel M Dupont; Henrik Gårdsvoll; Erin M Bekes; Cathrine K Thuesen; Zhuo Chen; Zhou Chen; Michael Ploug; James P Quigley; Peter A Andreasen
Journal:  Mol Cancer Res       Date:  2012-10-04       Impact factor: 5.852

8.  Does plasmin have anticoagulant activity?

Authors:  Jane Hoover-Plow
Journal:  Vasc Health Risk Manag       Date:  2010-04-15

9.  c-Met-induced epithelial carcinogenesis is initiated by the serine protease matriptase.

Authors:  R Szabo; A L Rasmussen; A B Moyer; P Kosa; J M Schafer; A A Molinolo; J S Gutkind; T H Bugge
Journal:  Oncogene       Date:  2011-01-10       Impact factor: 9.867

10.  Peptides with 6-Aminohexanoic Acid: Synthesis and Evaluation as Plasmin Inhibitors.

Authors:  Maciej Purwin; Agnieszka Markowska; Irena Bruzgo; Tomasz Rusak; Arkadiusz Surażyński; Urszula Jaworowska; Krystyna Midura-Nowaczek
Journal:  Int J Pept Res Ther       Date:  2016-09-19       Impact factor: 1.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.